Menu Search
Equities

Cencora Inc

COR:NYQ

Cencora Inc

Actions
Consumer Staples Personal Care, Drug and Grocery Stores
  • Price (USD)228.48
  • Today's Change-6.05 / -2.58%
  • Shares traded2.40m
  • 1 Year change+27.62%
  • Beta0.4440
Data delayed at least 15 minutes, as of Sep 19 2024 00:00 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Forecasts data is unavailable for this security.

Consensus recommendation

  • 14-Sep-23
  • 20-Jun-24
  • 18-Jul-24
  • 15-Aug-24
  • 18-Sep-24
Select bar for recommendation details.
Recommendations18-Sep-24
Buy4
Outperform8
Hold7
Sell0
Strong Sell0

Share price forecast in USD

The 15 analysts offering 12 month price targets for Cencora Inc have a median target of 263.00, with a high estimate of 284.00 and a low estimate of 240.00. The median estimate represents a 15.11% increase from the last price of 228.48.
High24.3%284.00
Med15.1%263.00
Low5.0%240.00

Dividends in USD

In 2023, Cencora Inc reported a dividend of 1.94 USD, which represents a 5.43% increase over last year. The 8 analysts covering the company expect dividends of 2.06 USD for the upcoming fiscal year, an increase of 6.19%.
Div growth (TTM)5.43%
More ▼

Earnings history & estimates in USD

On Jul 31, 2024, Cencora Inc reported 3rd quarter 2024 earnings of 3.34 per share. This result was in line with the consensus of the 14 analysts following the company and exceeded last year's 3rd quarter results by 14.38%.
The next earnings announcement is expected on Oct 31, 2024.
Average growth rate+4.09%
Cencora Inc reported annual 2023 earnings of 11.99 per share on Nov 02, 2023.
Average growth rate+14.11%
More ▼

Revenue history & estimates in USD

AmerisourceBergen Corporation had 3rd quarter 2024 revenues of 74.24bn. This bettered the 73.48bn consensus of the 11 analysts covering the company. This was 18.13% above the prior year's 3rd quarter results.
Average growth rate+2.75%
AmerisourceBergen Corporation had revenues for the full year 2023 of 262.17bn. This was 9.89% above the prior year's results.
Average growth rate+9.95%
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.